Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,070 | 12 | 57.7% |
| Travel and Lodging | $7,614 | 92 | 24.3% |
| Honoraria | $3,510 | 2 | 11.2% |
| Food and Beverage | $2,127 | 83 | 6.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BioXcel Therapeutics, Inc. | $30,363 | 137 | $0 (2024) |
| PFIZER INC. | $500.68 | 28 | $0 (2024) |
| ABBVIE INC. | $131.67 | 6 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $104.29 | 6 | $0 (2024) |
| Novo Nordisk Inc | $49.61 | 3 | $0 (2024) |
| Gilead Sciences, Inc. | $49.00 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $30.60 | 2 | $0 (2024) |
| Electromed, Inc. | $27.19 | 2 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $24.24 | 1 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $21.20 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $935.52 | 22 | BioXcel Therapeutics, Inc. ($520.00) |
| 2023 | $30,128 | 152 | BioXcel Therapeutics, Inc. ($29,843) |
| 2022 | $138.09 | 8 | PFIZER INC. ($119.50) |
| 2021 | $119.45 | 7 | PFIZER INC. ($65.70) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/27/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/18/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.23 | General |
| Category: Cardiovascular | ||||||
| 08/15/2024 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $520.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.85 | General |
| 07/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/27/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Cardio-renal | ||||||
| 05/29/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.71 | General |
| Category: Cardiovascular | ||||||
| 05/01/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/16/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.59 | General |
| 03/22/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/19/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/23/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/20/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/23/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/03/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/05/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Gastroenterology | ||||||
| 10/23/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 54 | 54 | $27,024 | $7,327 |
| 2020 | 4 | 230 | 238 | $103,694 | $30,910 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 37 | 37 | $16,977 | $4,806 | 28.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 17 | 17 | $10,047 | $2,521 | 25.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 164 | 168 | $72,738 | $22,381 | 30.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 29 | 29 | $17,139 | $4,395 | 25.6% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 20 | 20 | $8,252 | $2,535 | 30.7% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 17 | 21 | $5,565 | $1,599 | 28.7% |
About Mary Sands, NP
Mary Sands, NP is a Nurse Practitioner healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093729444.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mary Sands, NP has received a total of $31,321 in payments from pharmaceutical and medical device companies, with $935.52 received in 2024. These payments were reported across 189 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($18,070).
As a Medicare-enrolled provider, Sands has provided services to 284 Medicare beneficiaries, totaling 292 services with total Medicare billing of $38,237. Data is available for 2 years (2020–2021), covering 6 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Winston Salem, NC
- Active Since 07/28/2006
- Last Updated 03/07/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1093729444
Products in Payments
- IGALMI (Drug) $30,363
- ELIQUIS (Drug) $604.97
- TEFLARO (Drug) $88.20
- DALVANCE (Drug) $43.47
- Ozempic (Drug) $34.29
- SMARTVEST (Device) $27.19
- XIFAXAN (Drug) $24.24
- Kerendia (Drug) $21.20
- ULTOMIRIS (Biological) $20.06
- FARXIGA (Drug) $15.75
- Rybelsus (Drug) $15.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Winston Salem
Olivia Ogburn, Np, NP
Nurse Practitioner — Payments: $59,003
Christine Zdeb, Np, NP
Nurse Practitioner — Payments: $11,906
Eileen Tague, Np, NP
Nurse Practitioner — Payments: $7,571
Jennifer Davis, Agnp-C, AGNP-C
Nurse Practitioner — Payments: $6,979
Lillykutty Modoor, Nurse Practitioner, NURSE PRACTITIONER
Nurse Practitioner — Payments: $6,334
Dr. Charles Cook, Dnp, DNP
Nurse Practitioner — Payments: $5,968